Telemus Capital, LLC Bio Techne Corp Transaction History

Telemus Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 06, 2022	SELL	$353.85 - $487.79 $222,925 - $307,307	-630 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$456.15 - $525.06 $47,895 - $55,131	105 Added 20.0%	630 $326,000
Q3 2021 Oct 27, 2021	SELL	$444.87 - $538.88 $444 - $538	-1 Reduced 0.19%	525 $254,000
Q2 2021 Aug 09, 2021	BUY	$387.35 - $450.26 $203,746 - $236,836	526 New	526 $237,000

604

153M

171K

56.9K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.09B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Telemus Capital, LLC with notifications on news.